BPC-157 vs OTR-AC — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?
BPC-157 is a synthetic 15-amino acid peptide derived from gastric juice. It accelerates tissue repair, tendon healing, and gut protection via angiogenesis and growth hormone receptor upregulation. Orally bioavailable and stable in gastric acid. Extensive preclinical evidence acro...
Calculate BPC-157 dose →OTR-AC is the common name for oral high-dose BPC-157 acetate. The peptide sequence (GEPPPGKPADDAGLV) is identical to injectable BPC-157 but is dosed at 2–5 mg orally rather than 250–500 µg subcutaneously to compensate for GI degradation and first-pass metabolism. The oral route p...
Calculate OTR-AC dose →| Parameter | BPC-157 | OTR-AC |
|---|---|---|
| Category | Healing & Recovery | Healing & Recovery |
| Research | Extensively Studied | Preclinical |
| Half-Life | 4–6 hours | 4–6 hours (estimated, oral) |
| Typical Dose | 200–500 µg | 2–5 mg |
| Frequency | Once or twice daily | Once daily |
| Route | Subcutaneous / Oral | Oral |
| FDA Status | Not Approved | Not Approved |
Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.
For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.